FDA approves drug that can delay onset of T1D
The FDA has now approved the use of teplizumab (Tzield), the world’s first ever immunotherapy for Type 1 diabetes, by people at risk of Type
The FDA has now approved the use of teplizumab (Tzield), the world’s first ever immunotherapy for Type 1 diabetes, by people at risk of Type
At-home tests, once considered an anomaly, became de rigueur during the COVID-19 pandemic. Now, as COVID-19 testing rates decline from their pandemic peak, diagnostic companies
After analyzing 600 people wearing a continuous glucose monitor for an average of 12 days, Klick Applied Sciences says it can use data with artificial intelligence
Novo Nordisk has announced that UK users of the Abbott FreeStyle LibreLink app can now connect to its smart insulin pens. People living with diabetes
Eli Lilly has pulled out of a partnership with Ypsomed that would have given it a branded insulin pump to sell in the U.S. Lilly
According to a study published in The New England Journal of Medicine, the ability to customize open-source, “do-it-yourself” automated insulin delivery (AID) systems may make
Ascensia Diabetes Care has announced that it has updated its Eversense Continuous Glucose Monitoring system app to integrate with Apple Health. The new Apple Health
Roche has announced the introduction of the Navify brand to its digital health portfolio, which includes more than 30 digital solutions for labs, hospitals, and
Sernova’s Cell Pouch System is an implantable and scalable medical device that forms a natural environment in the body for the long-term survival and function
The substantial increase in obesity prevalence in the United States – from 30.5% to 41.9% in just the 2 decades from 2000 to 2020 –